Payment overview · 2025
General Payments
We did not find matching Open Payments records for this doctor in the selected program year.
Healthcare provider profile · identity verified
Tin Ha Ngoc, MD
Family Practice · GORHAM, ME · NPI 1073877791
Verified facts
What the public records show
We did not find matching Open Payments records for this doctor in 2025.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Analysis 1 · Payment-linked products
Products named in Open Payments records
No payment-linked product analysis is available because no matching General Payment records were found for the selected year.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
There is no payer-company set available for this comparison.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 408 | 115 |
| Lisinopril | Lisinopril | 342 | 95 |
| Omeprazole | Omeprazole | 324 | 90 |
| Amlodipine Besylate | Amlodipine Besylate | 291 | 79 |
| Levothyroxine Sodium | Levothyroxine Sodium | 262 | 72 |
| Hydrochlorothiazide | Hydrochlorothiazide | 220 | 58 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 206 | 65 |
| Metoprolol Succinate | Metoprolol Succinate | 198 | 56 |
| Losartan Potassium | Losartan Potassium | 194 | 50 |
| Simvastatin | Simvastatin | 185 | 52 |
| Tamsulosin Hcl | Tamsulosin Hcl | 169 | 46 |
| Gabapentin | Gabapentin | 167 | 47 |
| Sertraline Hcl | Sertraline Hcl | 148 | 40 |
| Oxycodone Hcl | Oxycodone Hcl | 137 | 21 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 129 | 55 |
| Clonazepam | Clonazepam | 123 | 17 |
| Pravastatin Sodium | Pravastatin Sodium | 121 | 35 |
| Furosemide | Furosemide | 117 | 43 |
| Eliquis | Apixaban | 111 | 24 |
| Metformin Hcl Er | Metformin Hcl | 111 | 37 |
| Metformin Hcl | Metformin Hcl | 110 | 30 |
| Famotidine | Famotidine | 107 | 30 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 107 | 32 |
| Trazodone Hcl | Trazodone Hcl | 107 | 26 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 97 | 35 |
| Jardiance | Empagliflozin | 93 | 19 |
| Prednisone | Prednisone | 91 | 72 |
| Glipizide Er | Glipizide | 90 | 27 |
| Lorazepam | Lorazepam | 87 | 19 |
| Allopurinol | Allopurinol | 74 | 24 |
| Escitalopram Oxalate | Escitalopram Oxalate | 74 | 24 |
| Tramadol Hcl | Tramadol Hcl | 74 | 16 |
| Metoprolol Tartrate | Metoprolol Tartrate | 72 | 21 |
| Ozempic | Semaglutide | 72 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 67 | 21 |
| Pantoprazole Sodium | Pantoprazole Sodium | 66 | 21 |
| Atenolol | Atenolol | 59 | 16 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 52 | 15 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 50 | 29 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 45 | suppressed |
| Alprazolam | Alprazolam | 41 | suppressed |
| Diazepam | Diazepam | 40 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 39 | 14 |
| Doxazosin Mesylate | Doxazosin Mesylate | 39 | 11 |
| Xarelto | Rivaroxaban | 39 | suppressed |
| Finasteride | Finasteride | 38 | suppressed |
| Potassium Chloride | Potassium Chloride | 38 | 12 |
| Trulicity | Dulaglutide | 38 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 37 | 11 |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 37 | 12 |
| Mirtazapine | Mirtazapine | 36 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 34 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 34 | 14 |
| Zolpidem Tartrate | Zolpidem Tartrate | 33 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 32 | suppressed |
| Carvedilol | Carvedilol | 30 | 11 |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 29 | suppressed |
| Ezetimibe | Ezetimibe | 29 | suppressed |
| Jantoven | Warfarin Sodium | 29 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 28 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 28 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 28 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 27 | suppressed |
| Irbesartan | Irbesartan | 26 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 26 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 26 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 26 | suppressed |
| Buprenorphine Hcl | Buprenorphine Hcl | 25 | suppressed |
| Bupropion Xl | Bupropion Hcl | 25 | 11 |
| Chlorthalidone | Chlorthalidone | 25 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 25 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 24 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 24 | 20 |
| Duloxetine Hcl | Duloxetine Hcl | 24 | 11 |
| Hydralazine Hcl | Hydralazine Hcl | 23 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 23 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 21 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 20 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 19 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 19 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 19 | suppressed |
| Meloxicam | Meloxicam | 19 | suppressed |
| Ondansetron Odt | Ondansetron | 19 | suppressed |
| Spironolactone | Spironolactone | 19 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 19 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 18 | suppressed |
| Hydrocortisone | Hydrocortisone | 18 | suppressed |
| Pregabalin | Pregabalin | 18 | suppressed |
| Synthroid | Levothyroxine Sodium | 18 | suppressed |
| Topiramate | Topiramate | 18 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 17 | suppressed |
| Estradiol | Estradiol | 17 | suppressed |
| Levetiracetam | Levetiracetam | 17 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 17 | suppressed |
| Testosterone | Testosterone | 17 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Arnuity Ellipta | Fluticasone Furoate | 16 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 16 | suppressed |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 16 | 16 |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 16 | suppressed |
| Myrbetriq | Mirabegron | 16 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 16 | 11 |
| Nitroglycerin | Nitroglycerin | 16 | 12 |
| Paroxetine Hcl | Paroxetine Hcl | 16 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 16 | suppressed |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 15 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 15 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 15 | suppressed |
| Glipizide | Glipizide | 15 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 15 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 14 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 14 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 14 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 14 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 14 | suppressed |
| Suboxone | Buprenorphine Hcl/Naloxone Hcl | 14 | suppressed |
| Buprenorphine | Buprenorphine | 13 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 13 | suppressed |
| Dulera | Mometasone/Formoterol | 13 | suppressed |
| Lovastatin | Lovastatin | 13 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 13 | suppressed |
| Primidone | Primidone | 13 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 13 | suppressed |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 13 | 11 |
| Advair Diskus | Fluticasone Propion/Salmeterol | 12 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 12 | 11 |
| Ibuprofen | Ibuprofen | 12 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 12 | suppressed |
| Mupirocin | Mupirocin | 12 | 11 |
| Oxycontin | Oxycodone Hcl | 12 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 12 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 12 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 11 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 11 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 11 | suppressed |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 11 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 11 | 11 |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | — | — | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error